Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Journal of Applied Crystallography|June 3, 2026
Design of polychromatic focusing optics for neutron reflectometers: rethinking REFocus opticsNorifumi L Yamada, Masahiro Hino, Ryuji Maruyama, et al.
Nihon Ishinkin Gakkai Zasshi = Japanese Journal of Medical Mycology|November 15, 2003
[Prevention of dermatophytoses]Ryuji Maruyama, Kunitaro Fukuyama, Takuro Katoh, et al.
Optics Express|April 15, 2009
Figuring of plano-elliptical neutron focusing mirror by local wet etchingKazuya Yamamura, Mikinori Nagano, Hiroyuki Takai, et al.
Langmuir : the ACS Journal of Surfaces and Colloids|September 20, 2025
Effect of Short-Term Thermal Annealing on the Nanostructure of Nafion Thin Films on Platinum SubstratesShigeki Uzuki, Masako Yamada, Reiji Kumai, et al.
The Journal of Dermatology|March 9, 2021
Validation of a lateral flow immunochromatographic assay for tinea unguium diagnosisRyoji Tsuboi, Takashi Mochizuki, Haruo Ito, et al.
Allergology International : Official Journal of the Japanese Society of Allergology|July 14, 2026
Randomized phase 2a study of TAS5315, a Bruton's tyrosine kinase inhibitor, for chronic spontaneous urticariaMichihiro Hide, Atsushi Fukunaga, Koremasa Hayama, et al.
The Journal of Dermatology|September 26, 2020
Guidelines for the management of dermatomycosis (2019)Takashi Mochizuki, Ryoji Tsuboi, Ken Iozumi, et al.
The Journal of Dermatology|May 27, 2021
A phase III, 52-week, open-label study to evaluate the safety and efficacy of 5% sofpironium bromide (BBI-4000) gel in Japanese patients with primary axillary hyperhidrosisTomoko Fujimoto, Yoichiro Abe, Masaru Igarashi, et al.
The Journal of Dermatology|January 7, 2021
A phase 3, multicenter, randomized, double-blind, vehicle-controlled, parallel-group study of 5% sofpironium bromide (BBI-4000) gel in Japanese patients with primary axillary hyperhidrosisHiroo Yokozeki, Tomoko Fujimoto, Yoichiro Abe, et al.
The Journal of Dermatology|July 2, 2021
Clinical effectiveness of efinaconazole 10% solution for treatment of onychomycosis with longitudinal spikesShinichi Watanabe, Ken Iozumi, Masatoshi Abe, et al.
Pageof 2